KB
Krystal Biotech Inc
🇺🇸XNAS.KRYSUnited StatesHealthcare
$335.42USDdown -4.61 (-1.36%)ClosedEnd of day9:46 PM
Price$335.42-4.61 (-1.36%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US5011471027
- CUSIP
- 501147102
Company
- Employees
- 295
- Headquarters
- Pittsburgh, United States
- Website
- https://www.krystalbio.com
- CEO
- Mr. Krish S. Krishnan M.B.A., M.S.
Market
- Shares outstanding
- 29.6M
- Market cap
- $9.93B
Key dates
- Next earnings
- Nov 2, 2026
Highlights
- Market cap
- $9.93B
- EPS LTM
- $8.16calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- 41.12calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $440.48M+22.63%up year on year
- Net income
- $241.47M+64.57%up year on year
- Gross margin
- 93.34%-0.03%down year on year
- Free cash flow
- $257.78M+39.01%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.